Paclitaxel Injection Market Size, Share, Industry Analysis, Segments And Forecast To 2033

"The new report published by The Business Research Company, titled ""Paclitaxel Injection Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the paclitaxel injection market size has grown rapidly in recent years. It will grow from $5.26 billion in 2023 to $6.02 billion in 2024 at a compound annual growth rate (CAGR) of 14.4%. The paclitaxel injection market size is expected to see rapid growth in the next few years. It will grow to $9.85 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13211&type=smp

Rising Incidence Of Breast Cancer Fuels Growth In The Paclitaxel Injection Market
The growing incidence of breast cancer is expected to propel the growth of the paclitaxel injection market going forward. Breast cancer is a disease in which cells in the breast grow abnormally and can form a tumor, a lump of tissue that spreads to other parts of the body. Paclitaxel injection is a chemotherapy drug used to treat breast cancer by binding to the microtubules, which are structures that help to hold the cancer cells together, stopping the growth of cancer cells. For instance, in January 2023, according to the American Cancer Society, a US-based cancer-fighting organization, it is estimated that around 297,790 new cases of invasive breast cancer are expected to be diagnosed in the US, and 43,700 deaths are expected to occur from breast cancer in 2023. Therefore, the growing incidence of breast cancer is driving the growth of the paclitaxel injection market.

Innovative Advancements In Paclitaxel Injection Market
Major companies operating in the paclitaxel injection market are developing innovative products with advanced materials, such as protein-bound particles, to provide reliable services to the consumers. Protein-bound particles (PBPs) are a drug delivery system that uses albumin, a naturally occurring protein in the blood, to bind to a drug. For instance, in April 2022, Apotex Corp, a US-based pharmaceutical company, launched Paclitaxel protein-bound particles for injection (albumin-bound), a generic version of Abraxanes for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, and the treatment of metastatic breast cancer. It is administered as an intravenous infusion and launched by American Regent, Inc. as an alternative to Abraxane.

The paclitaxel injection market covered in this report is segmented -

1) By Type: Natural Paclitaxel, Semi-synthetic Paclitaxel
2) By Drug Strength: 10mg/mL, 20mg/mL, 30mg/mL
3) By Indication: Breast Cancer, Prostate Cancer, Testicular Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
5) By End User: Hospitals, Clinics, Cancer Research Institute

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13211&type=discount

Major companies operating in the paclitaxel injection market report are Pfizer Inc., Bristol-Myers Squibb Company, Fresenius Kabi Oncology Ltd., Abbott Laboratories, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz International GmbH, Hospira Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Torrent Pharmaceuticals Ltd., Luye Pharma Group, Biological E Limited, Alembic Pharmaceuticals Limited, Khandelwal Laboratories Pvt. Ltd., Gland Pharma Limited, Abraxis Bio Science Inc., Novasep Holding SAS, Sagent Pharmaceuticals Inc., Hainan Haiyao Co Ltd., Accord Healthcare Ltd., Natco Pharma Limited, Strides Pharma Science Limited, Panacea Biotec Ltd., American Regent Inc., MSN Laboratories Pvt Ltd., Hetero Drugs Ltd.

Contents of the report:
1. Executive Summary
2. Paclitaxel Injection Market Report Structure
3. Paclitaxel Injection Market Trends And Strategies
4. Paclitaxel Injection Market - Macro Economic Scenario
5. Paclitaxel Injection Market Size And Growth
…..
27. Paclitaxel Injection Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/paclitaxel-injection-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.